News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
Novo Nordisk 1Q26 Adjusted Operating Profit Falls 15% YoY, Beats Forecast
Novo Nordisk, the maker of weight-loss drug Wegovy, announced its quarterly results. Adjusted operating profit for 1Q26 amounted to 32.86 billion Danish kroner (USD5.16 billion), d...
Reset
Send
The window will close in 5 seconds
Novo Nordisk 1Q26 Adjusted Operating Profit Falls 15% YoY, Beats Forecast
Close
Recommend
4
Positive
3
Negative
0
 
 

Novo Nordisk, the maker of weight-loss drug Wegovy, announced its quarterly results. Adjusted operating profit for 1Q26 amounted to 32.86 billion Danish kroner (USD5.16 billion), down 15% YoY, or down 6% YoY at constant exchange rates, above market expectations of 28.74 billion Danish kroner. Quarterly net sales rose 24% YoY to 96.823 billion Danish kroner, or up 32% YoY at constant exchange rates.

The company expects full-year adjusted sales and operating profit to decline by 4% to 12% at constant exchange rates, compared with its previous forecast range of a 5% to 13% decline. CEO Mike Doustdar said in a statement that the strong performance of Wegovy, coupled with continued growth in international operations, prompted the company to raise its related guidance.

Related NewsEIA Crude Oil Stocks Change for May/08 in the United States is -4.306M, lower than the previous value of -2.313M. The forecast was -2.10M.
Novo Nordisk had enjoyed a window as the only oral weight-loss drug provider in the US market, but this period ended early last month after a competing drug, Foundayo, developed by Eli Lilly and Company (LLY.US)      , received approval from the US Food and Drug Administration. Eli Lilly and Company also raised its full-year earnings and revenue forecasts last week. (fc/w)(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.